alpha-methylornithine has been researched along with Psoriasis in 1 studies
alpha-methylornithine: inhibitor of ornithine decarboxylase; RN given refers to cpd without isomeric designation
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grosshans, E | 1 |
| Henry, M | 1 |
| Tell, G | 1 |
| Schechter, PJ | 1 |
| Böhlen, P | 1 |
| Grove, J | 1 |
| Koch-Weser, J | 1 |
1 other study available for alpha-methylornithine and Psoriasis
| Article | Year |
|---|---|
[Polyamines in psoriasis].
Topics: Anthralin; Carboxy-Lyases; Chemical Phenomena; Chemistry; Double-Blind Method; Eflornithine; Humans; | 1980 |